| Literature DB >> 30857637 |
Yoshihiro Nitta1, Mitsuru Miyachi2, Akimasa Tomida3, Yohei Sugimoto4, Norio Nakagawa5, Hideki Yoshida6, Kazutaka Ouchi7, Kunihiko Tsuchiya8, Tomoko Iehara9, Eiichi Konishi10, Katsutsugu Umeda11, Takeshi Okamoto12, Hajime Hosoi13.
Abstract
Lipoblastoma is a rare benign adipose tissue tumor that occurs mostly in infants and children. Histological diagnosis of lipoblastoma is sometimes difficult because it closely resembles other lipomatous tumors. The detection of PLAG1 gene rearrangement is useful for the diagnosis of lipoblastoma. Four PLAG1 fusion partner genes are known in lipoblastoma: HAS2 at 8q24.1, COL1A2 at 7q22, COL3A1 at 2q32, and RAB2A at 8q12. Herein, we describe a novel fusion gene in a case of lipoblastoma of left back origin. We identified a potential PLAG1 fusion partner using 5' rapid amplification of cDNA ends, and sequence analysis revealed the novel fusion gene, BOC-PLAG1. The BOC-PLAG1 fusion transcript consists of the first exon of the BOC gene fused to exon 2 or exon 3 of the PLAG1 gene. PLAG1 expression was found to be 35.7 ± 2.1 times higher in the tumor specimen than in human adipocytes by qRT-PCR. As a result of the translocation, the constitutively active promoter of BOC leads to PLAG1 overexpression. The identification of the BOC-PLAG1 fusion gene will lead to more accurate diagnosis of lipoblastoma.Entities:
Keywords: BOC; Childhood cancer; Fusion gene; Lipoblastoma; PLAG1
Mesh:
Substances:
Year: 2019 PMID: 30857637 DOI: 10.1016/j.bbrc.2019.02.154
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575